Carol Ann Satler, MD, PhD
Physician executive with more than 25 years of experience in health care industry including 10 years in clinical practice and more than 15 years in pharmaceutical industry. Carol built, led and managed teams across different therapeutics areas (cardiovascular, thrombosis, metabolism, respiratory, hematology/oncology, immunology, neurology, pediatrics & rare diseases). Held leadership roles in clinical research and development, medical affairs, and administration in US and globally (France & UK) at major pharmaceutical companies including Gilead, Bayer, Pfizer, Sanofi, Millennium & UCB. Outstanding accomplishments include formulating strategic clinical development plans, life cycle management and commercialization of products each with annual revenues in excess of $1 billion including Plavix (clopidogrel), Lipitor (atorvastatin), Lovenox (enoxaparin), Norvasc (amlodipine), Velcade (bortezomib) and Avapro/Avalide (irbesartan).